Breaking News
March 25, 2019 - Breast Density Categorization Varies With Screening Modality
March 25, 2019 - Researchers explore link between metal exposure and Parkinson’s symptoms
March 25, 2019 - Around one in hundred people has autism spectrum condition in China
March 25, 2019 - Research paves way for new standard of care to improve heart’s pump function
March 25, 2019 - Exposure to HIV virus, antiretroviral therapy before birth linked to obesity and asthma-like symptoms
March 25, 2019 - Transgender men preserve their fertility potential after one year of testosterone therapy
March 25, 2019 - Tighter Blood Pressure Control May Prevent Brain Lesions
March 25, 2019 - A reward now or later? Exploring impulsivity in Parkinson’s disease patients
March 25, 2019 - Financial incentives fail to increase completion rates of colorectal cancer screening tests mailed to patients
March 25, 2019 - New research program launched to highlight sexual harassment in academia
March 25, 2019 - Hemoglobin A1c blood test does not detect diabetes in most patients, shows study
March 25, 2019 - Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics
March 25, 2019 - DWK Life Sciences launches KIMBLE GLS 80 Media Bottle and Multiport Cap System
March 25, 2019 - New study aims to reduce online sexual exploitation of children
March 25, 2019 - Want healthier eating habits? Start with a workout
March 25, 2019 - New approach to prescribing antibiotics could curb resistance
March 24, 2019 - Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
March 24, 2019 - Prenatal DHA prevents blood-pressure increase from obesity during childhood
March 24, 2019 - Combined immunosuppression may be effective, safe in treating older patients with Crohn’s disease
March 24, 2019 - GSK sells health drinks arm, buys US cancer treatment firm
March 24, 2019 - Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births
March 24, 2019 - IgG antibodies play unexpected role in atherosclerosis
March 24, 2019 - Sounds and vibrations are quite similar for the brain, finds new study
March 24, 2019 - Practices for Reducing COPD Hospital Readmissions Explored
March 24, 2019 - Could an eye doctor diagnose Alzheimer’s before you have symptoms?
March 24, 2019 - Enzyme inhibitor stops inflammation and neurodevelopmental disorders in mouse models
March 24, 2019 - Walk, Dance, Clean: Even a Little Activity Helps You Live Longer
March 24, 2019 - Americans used less eye care in 2014 versus 2008
March 24, 2019 - Study finds link between depression in 20s linked to memory loss in 50s
March 24, 2019 - New tool helps physiotherapy students to master complex fine motor skills
March 24, 2019 - The AMR Centre secures £2.3m funding boost
March 24, 2019 - Study examines effects of taking ondansetron during first trimester of pregnancy
March 24, 2019 - Researchers identify a more effective treatment for cancer
March 24, 2019 - Open-source solution for multiparametric optical mapping of the heart’s electrical activity
March 24, 2019 - New nanotechnology approach shows promise in treating triple negative breast cancer
March 24, 2019 - Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
March 24, 2019 - Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
March 24, 2019 - Apple watch could detect irregular heart beat says study
March 24, 2019 - Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
March 24, 2019 - Girls should be encouraged to gain more ball skills, shows study
March 24, 2019 - Acute doses of synthetic cannabinoid can impair critical thinking and memory
March 24, 2019 - Presence of bacteria in urine does not always point to infection, shows study
March 24, 2019 - Scientists identify a new role for nerve-supporting cells
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
Stanford researchers find that small molecule may help treat enzyme deficiency

Stanford researchers find that small molecule may help treat enzyme deficiency

image_pdfDownload PDFimage_print

Scientists are one step closer to developing a treatment for a genetic enzyme deficiency that can cause red blood cells to break down in response to infections or certain drugs or foods, like fava beans. In extreme cases, reactions can be fatal.

The research, led by Stanford’s Daria Mochly-Rosen, PhD, and Sunhee Hwang, PhD, identified a small molecule that can patch up the defective enzyme. The goal is to convert this molecule into a safe daily treatment for people with the enzyme deficiency.

The research appears in Nature Communications.

When it functions properly, the enzyme, called glucose-6-phosphate dehydrogenase or G6PD, protects red blood cells from oxidative stress, which occurs when unstable atoms called free radicals steal electrons from red blood cells’ protective membrane, causing them to break down.

However more than 400 million individuals worldwide are born with mutated G6PDs, leaving their cells more susceptible to oxidative stress and deterioration. When exposed to specific foods, medications, infections or environmental factors, patients can experience hemolytic anemia, where their red blood cells are destroyed faster than the body can produce them. This results in symptoms such as abdominal pain, increased heart rate, shortness of breath, fever, jaundice and brain damage in severe cases or if left untreated.

Many of the people with the G6PD mutation live where malaria is common. Unfortunately, chloroquine, a commonly used antimalarial drug in low and middle income countries, is known to trigger hemolytic anemia in G6PD-deficient patients. Due to limited resources, malaria patients in these regions are rarely tested for G6PD deficiency before taking chloroquine. This puts individuals with the disorder in a dangerous predicament.

Mochly-Rosen and Hwang don’t believe that patients should have to choose between malaria or a hemolytic episode.

They thought the molecule they had found, known as activator of G6PD-1 (abbreviated as AG1), might provide some protection from the condition. To see, the researchers and collaborator Karen Mruk, PhD, exposed zebrafish embryos to chloroquine, causing blood to pool in the veins and physical changes in the embryo’s structure. Incredibly, when they treated the embryos with AG1, they noticed a decrease in both oxidative stress and the physical defects. Long term, the goal is to give a drug similar to AG1 together with chloroquine for people with G6PD deficiency who are exposed to malaria.

However, moving from fish to humans is a tricky business.

Along with correcting G6PD-deficiency, AG1 has an additional purpose. By testing AG1 on human blood samples, the team found that the molecule helps prolong red blood cells’ 42-day shelf-life by reducing the rate of hemolysis. This could be a huge help in lengthening the amount of available time between blood donation and transfusion.

But, “even though we have some promising data, this molecule is quite a mild activator,” Hwang said. “We want to increase the mutant G6PD enzyme activity to 60 percent of the normal enzyme, which is known to be sufficient in humans. As of now, we have only activated it by 20 or 30 percent.”

Currently, Andrew Raub, a graduate student who is working in the Mochly-Rosen lab, is trying to make a new form of AG1 that can be used in human trials. By examining the crystal structure of AG1, the team can understand where the molecule binds and create a more stable and effective drug.

And the new molecule could help with more than just red blood cells, Mochly-Rosen believes.

“It is assumed that the deficiency in this enzyme is only important for maintaining the integrity of red blood cells,” Mochly-Rosen said. “But I’m quite confident that this is really an underestimation of the contribution of this mutation to human health.”

For Mochly-Rosen, this study also holds personal significance. In addition to activator of G6PD, the acronym AG stands for the initials of the University of California, San Francisco professor and neuroscientist Adrienne Gordon, a close friend and mentor of Mochly-Rosen who died in 2015. “She was my mentor since graduate school, I was always bouncing ideas against her, and she love this G6PD project. And so, we named the molecule AG for her as well.”

Photo of Sunhee Hwang, at left, and Daria Mochly-Rosen by Helen Santoro

Tagged with:

About author

Related Articles